Notice of preliminary results

London, February 4, 2020 – Hikma Pharmaceuticals PLC (Hikma, Group / LSE: HIK / NASDAQ Dubai: HIK / OTC: HKMPY) (rated Ba1/stable Moody’s and BB+/positive S&P), will announce its preliminary financial results for the year ended 31 December 2019 on Thursday 27 February 2020.

Press Release Corporate 4 February 2020

A presentation and webcast for analysts will be held on 27 February 2020 at 9:30am GMT, for further information about the meeting, please get in contact with Tiina Lugmayer –

To join via conference call please dial:

United Kingdom 0800 640 6441

United Kingdom (local) 020 3936 2999

All other locations +44 20 3936 2999

Access code: 442936

The results presentation and a webcast recording of the event will be available on the Company's website at or

Playback facility:

A playback of the conference call will be available up to six months after the presentation.

UK: 020 3936 3001

USA: 1 845 709 8569

All other locations: +44 20 3936 3001

Access code: 169303

Important notice for users

You are about to access Hikma historic archive material. Any reference in these archives to Hikma products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data, or safety data. Please refer to your approved national product label (SmPC) for current product information.

I have read this warning and will not be using any of the contained product information for clinical purposes.